The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Magnetic hyperthermia uses the targeted therapeutic heat from magnetic particles (MPs) in an alternating magnetic field to kill cancer cells. MPs with low Curie temperature (Tc) (in the range 42 °C–45 °C), high magnetization, and magnetic permeability/susceptibility are good candidates for their use in hyperthermia therapy. This paper analyzes the hyperthermic effects determined by the MPs with low...
Magnetic hyperthermia is a clinical therapy which uses the heat given by the magnetic nanoparticles (MNPs) in alternating magnetic fields for the treatment of various cancers. The control of temperature within the tumor and healthy tissues is an important step for the success of this therapy. This paper analyzes the temperature field determined by the heating of FeCrNbB systems injected within a tumor...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.